Compared to the control, MG132 treatment did not change the TRAF3 ubiquitination level (Figure 2D), suggesting that TRAF3 barely undergoes K48-linked ubiquitination at 6 h after viral infection. This evidence concerns the gene TRAF3 and viral infectious disease.